Summary
Partnering at Bayer Schering PharmaOrganization name
Bayer Schering Pharma Business DevelopmentProfile
Improving patients' quality of life with innovations
Bayer Schering Pharma invests large sums in research and development to improve patients' quality of life and prolong their lives.
The focus is on therapeutic areas with a high medical need, for example cancer therapy, where more innovations are needed despite considerable progress. In this context, Bayer Schering Pharma focuses on its core competencies and builds on many years of research experience.
Focus on therapy areas with a high medical need
In its internal research for active ingredients, Bayer Schering Pharma concentrates on four core areas: Oncology, Cardiology, Women´s Healthcare, and Diagnostic Imaging. With new approaches in cancer therapy, cardiovascular diseases, gynecological therapies, and molecular imaging, they aim to become the innovation leader in these areas.
BayerSchering is especially interested in:
Oncology/Tumor Diseases
- CLL (Chronic lymphocytic leukemia)
- Other leukemia
- Non-Hodgkin's lymphom
- Solid tumors
Hematology and Cardiology
- Blood coagulation
- Thromboembolytic disorders
- Peripheral arterial occlusive diseases
Women's Healthcare
- Hormonal contraception
- Climaterium
- Gynecological therapy
Primary Care
- Infections
- Men's Healthcare
- Cardiovascular diseases
- Metabolic disorders
- Erectile dysfunction
Specialized Therapeutics
- Multiple Sclerosis
- Parkinson Disease
Diagnostic Imaging
- X-Ray Contrast Media
- MRI Contrast Media
- PET Imaging Agents
Partnering
To be able to develop innovative products, a company needs an appropriate environment - in Germany, in Europe and worldwide - and strong partners. With a global network of external scientific and industrial development partners, they strengthen our own research infrastructure and, therefore, assure the long-term success of our product pipeline. To supplement our internal efforts, we collaborate with several companies in different stages of the typical pharmaceutical research cycle.
Bayer Schering offers an contact form to submit technology offers online.
print this page
